Lilly immunology deal starts Phase 1
Lilly’s $2.88 billion immunology deal has started Phase 1.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.